Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.

@article{Frazier2012NeurocognitiveOI,
  title={Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.},
  author={Jean A. Frazier and Anthony J. Giuliano and Jacqueline L Johnson and Lauren J. Yakutis and Eric A Youngstrom and David Breiger and Linmarie Sikich and Robert L. Findling and Jon Mcclellan and Robert M. Hamer and Benedetto Vitiello and Jeffrey A. Lieberman and Stephen R. Hooper},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2012},
  volume={51 5},
  pages={
          496-505
        }
}
OBJECTIVE To assess neurocognitive outcomes following antipsychotic intervention in youth enrolled in the National Institute of Mental Health (NIMH)-funded Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS). METHOD Neurocognitive functioning of youth (ages 8 to 19 years) with schizophrenia or schizoaffective disorder was evaluated in a four-site, randomized, double-blind clinical trial comparing molindone, olanzapine, and risperidone. The primary outcomes were overall group… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

Similar Papers

Loading similar papers…